Literature DB >> 7836935

Voltage-dependent regulation of modal gating in the rat SkM1 sodium channel expressed in Xenopus oocytes.

S Ji1, W Sun, A L George, R Horn, R L Barchi.   

Abstract

The TTX-sensitive rat skeletal muscle sodium channel (rSkM1) exhibits two modes of inactivation (fast vs slow) when the alpha subunit is expressed alone in Xenopus oocytes. In this study, two components are found in the voltage dependence of normalized current inactivation, one having a V1/2 in the expected voltage range (approximately -50 mV, I(N)) and the other with a more hyperpolarized V1/2 (approximately -130 mV, IH) at a holding potential of -90 mV. The I(N) component is associated with the gating mode having rapid inactivation and recovery from inactivation of the macroscopic current (N-mode), while IH corresponds to the slow inactivation and recovery mode (H-mode). These two components are interconvertible and their relative contribution to the total current varies with the holding potential: I(N) is favored by hyperpolarization. The interconversion between the two modes is voltage dependent and is well fit to a first-order two-state model with a voltage dependence of e-fold/8.6 mV and a V1/2 of -62 mV. When the rat sodium channel beta 1-subunit is coinjected with rSkM1, IH is essentially eliminated and the inactivation kinetics of macroscopic current becomes rapid. These two current components and their associated gating modes may represent two conformations of the alpha subunit, one of which can be stabilized either by hyperpolarization or by binding of the beta 1 subunit.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836935      PMCID: PMC2229229          DOI: 10.1085/jgp.104.4.625

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  15 in total

1.  Single-channel analysis of inactivation-defective rat skeletal muscle sodium channels containing the F1304Q mutation.

Authors:  J H Lawrence; D W Orias; J R Balser; H B Nuss; G F Tomaselli; B O'Rourke; E Marban
Journal:  Biophys J       Date:  1996-09       Impact factor: 4.033

2.  Tail currents in the myelinated axon of Xenopus laevis suggest a two-open-state Na channel.

Authors:  F Elinder; P Arhem
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

3.  The equine periodic paralysis Na+ channel mutation alters molecular transitions between the open and inactivated states.

Authors:  W J Hanna; R G Tsushima; R Sah; L J McCutcheon; E Marban; P H Backx
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

4.  Modulation of Na+ channel inactivation by the beta 1 subunit: a deletion analysis.

Authors:  C Chen; S C Cannon
Journal:  Pflugers Arch       Date:  1995-12       Impact factor: 3.657

5.  Modal behavior of the mu 1 Na+ channel and effects of coexpression of the beta 1-subunit.

Authors:  S Y Chang; J Satin; H A Fozzard
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

6.  Sodium channel isoform-specific effects of halothane: protein kinase C co-expression and slow inactivation gating.

Authors:  M K Patel; D Mistry; J E John; J P Mounsey
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.

Authors:  N Yang; S Ji; M Zhou; L J Ptácek; R L Barchi; R Horn; A L George
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  P2 receptor modulation of voltage-gated potassium currents in Brown adipocytes.

Authors:  S M Wilson; P A Pappone
Journal:  J Gen Physiol       Date:  1999-01       Impact factor: 4.086

9.  Gating properties of a sodium channel with three arginines substituted by histidines in the central part of voltage sensor S4D4.

Authors:  F J P Kühn; N G Greeff
Journal:  J Membr Biol       Date:  2003-05-01       Impact factor: 1.843

Review 10.  Critical illness myopathy and polyneuropathy.

Authors:  Shawn J Bird; Mark M Rich
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.